Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90 (CROSBI ID 192850)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Matokanović, Mirela ; Barišić, Karmela ; Filipović-Grčić, Jelena ; Maysinger, Dušica Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90 // European journal of pharmaceutical sciences, 50 (2013), 1; 149-158. doi: 10.1016/j.ejps.2013.04.001

Podaci o odgovornosti

Matokanović, Mirela ; Barišić, Karmela ; Filipović-Grčić, Jelena ; Maysinger, Dušica

engleski

Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90

Inducers of heat shock protein 70 (Hsp70) commonly promote cancer cell viability whereas inhibitors of Hsp90 reduce it. The anticancer agent celastrol, interferes with signal transduction pathways involving these heat shock proteins. The objective of this in vitro study was to silence inducible Hsp70 and to pro- mote celastrol-induced tumor cell death. Hsp70 siRNA loaded chitosan- TPP carriers were prepared by ionic gelation and characterized by photon correlation spectroscopy and asymmetric flow field-flow frac- tionation combined with dynamic light scattering. Viability of human leukemia and glioblastoma cells and Hsp70 silencing was determined following treatment with chitosan-TPP-Hsp70 siRNA particles. The results showed that silencing of Hsp70 by chitosan- TPP-Hsp70 siRNA treatment significantly reduced cell viability, and enhanced antiproliferative effects of celastrol in leukemia and glioblastoma cells. In glioblastoma spheroids, higher concentrations of celastrol and Hsp70 siRNA in chitosan-TPP nanocarriers were necessary to induce cell death.

cancer; Hsp70; Chitosan; siRNA nanocarriers; celastrol; tumor spheroids

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

50 (1)

2013.

149-158

objavljeno

0928-0987

10.1016/j.ejps.2013.04.001

Povezanost rada

Farmacija

Poveznice
Indeksiranost